Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01679301 · ClinicalTrials.gov registry record · NA
Evaluation of Sleep Mode Within the Respironics SimplyGo Portable Oxygen Concentrator
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01679301: Completed NA study, sponsored by Philips Respironics.
NCT01679301 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01679301, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The SimplyGo Study is a single site, cross-over study which aims to enroll a maximum of 30 participants (to allow for 20 completed data sets) with a prescription for nocturnal oxygen, and meeting all eligibility criteria.
Primary Outcome
A comparison of the average oxygen saturation values obtained via pulse oximetry during continous flow oxygen versus 'sleep' mode while sleeping
Interventions
- DEVICE Pulse Dose (Sleep Mode)
- DEVICE Continuous Dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2012-09 |
| Est. Completion | 2014-07 |
| Phase | NA |
What the finished NCT01679301 record still lists
NCT01679301 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Pulse Dose (Sleep Mode) is the first listed.
NCT01679301 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01679301 about?
NCT01679301 is a clinical study titled "Evaluation of Sleep Mode Within the Respironics SimplyGo Portable Oxygen Concentrator". The SimplyGo Study is a single site, cross-over study which aims to enroll a maximum of 30 participants (to allow for 20 completed data sets) with a prescription for nocturnal oxygen, and meeting all eligibility criteria.
What is the current status of trial NCT01679301?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2012-09. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01679301?
The interventions under investigation include: Pulse Dose (Sleep Mode) (DEVICE), Continuous Dose (DEVICE).
Who is sponsoring clinical trial NCT01679301?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01679301's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia